Max Healthcare Institute Ratios

Max Healthcare Institute Ltd Ratios

The Max Healthcare Institute Ltd Ratios page provides a complete fundamental analysis of Max Healthcare Institute Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Max Healthcare Institute Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Max Healthcare Institute Ltd (NSE: MAXHEALTH, BSE: 543220) is currently trading at ₹962.30, with a market capitalization of ₹935.82B. As a major player in the Health services sector and Hospital/Nursing management industry, Max Healthcare Institute Ltd remains a key stock for fundamental analysis using Max Healthcare Institute Ltd Ratios.

Max Healthcare Institute Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Max Healthcare Institute Ltd P/E ratio currently stands at 99.63, making it one of the most tracked metrics in Max Healthcare Institute Ltd Ratios.

Historically, the Max Healthcare Institute Ltd P/E ratio has shown strong fluctuations:

• 2024: 99.63
• 2023: 75.67
• 2022: 38.83
• 2021: 55.58
• 2020: 0

The rising Max Healthcare Institute Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Max Healthcare Institute Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 11.37.

Historical P/B trend:

• 2024: 11.37
• 2023: 9.48
• 2022: 5.78
• 2021: 5.35

Max Healthcare Institute Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Max Healthcare Institute Ltd P/S ratio currently stands at 15.30, an important part of Max Healthcare Institute Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 15.30
• 2023: 14.86
• 2022: 9.42
• 2021: 8.57

The rising Max Healthcare Institute Ltd P/S ratio indicates improved revenue valuation by investors.

Max Healthcare Institute Ltd Price to Cash Flow Ratio (P/CF)

The Max Healthcare Institute Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 73.51.

Historical Max Healthcare Institute Ltd Price to Cash Flow Ratio:

• 2024: 73.51
• 2023: 72.57
• 2022: 34.55
• 2021: 45.29
• 2020: 105.84

The rising Max Healthcare Institute Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Max Healthcare Institute Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Max Healthcare Institute Ltd EV currently stands at ₹1100B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 1100B
• 2023: 804.4B
• 2022: 422.93B
• 2021: 342.67B

Max Healthcare Institute Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Max Healthcare Institute Ltd EV/EBITDA ratio is currently 57.42, a key metric in Max Healthcare Institute Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 57.42
• 2023: 52.89
• 2022: 33.60
• 2021: 29.69

Higher Max Healthcare Institute Ltd EV/EBITDA suggests premium valuation.

Max Healthcare Institute Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Max Healthcare Institute Ltd D/E ratio is currently 0.32, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.32
• 2023: 0.18
• 2022: 0.12
• 2021: 0.18

Max Healthcare Institute Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Max Healthcare Institute Ltd ROE currently stands at 12.10%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 12.10
• 2023: 13.37
• 2022: 16.12
• 2021: 10.15

Max Healthcare Institute Ltd maintains stable profitability levels.

Max Healthcare Institute Ltd Ratios Analysis Summary

The Max Healthcare Institute Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Max Healthcare Institute Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Max Healthcare Institute Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.